Background
Methods
Search strategy
Inclusion and exclusion criteria
Quality assessment
Assessment of publication bias and influence analysis
Results
Results of the systematic literature search
Author (publication year) | Country | City | Period of the study |
---|---|---|---|
Lucia Sanchez Ramos (2018) [20] | Germany | Leipzig | NM |
Mervi Gürsoy (2017) [21] | Finland | Turku | NM |
Belén Rodríguez-Sánchez (2017) [22] | Spain | Madrid | January 2010 to August 2012. |
A.C.M. Veloo (2016) [23] | The Netherlands | Groningen | NM |
Tomoyuki Yunoki (2016) [24] | Japan | Kyoto | June 2013 to May 2014 |
Sung Jin Jo, M.D. (2015) [25] | Korea | Seoul | January to February 2015 |
NINA HANDAL (2014) [26] | Norway | Lørenskog | January 2009 to December 2013 |
Wonmok Lee, M.D. (2014) [27] | Korea | Seoul | 2011 |
M.J. Barba (2014) [28] | Spain | A Coruña | 2007–2014 |
Roy Chean (2014) [29] | Australia | Melbourne | 2000–2010 |
Mariela S. Záratea (2014) [30] | Argentina | Ciudad Autónoma de Buenos Aires | NM |
Yang Li (2014) [31] | China | Nanjing | NM |
Yen-Michael S. Hsu (2014) [32] | USA | St. Louis | NM |
Susanna K P Lau (2013) [33] | China | Hong Kong | NM |
O. Garner (2013) [34] | USA | St. Louis | January 2012 to August 2012. |
Melody Barreau(2013) [35] | France | Marseille | 2010–2013 |
L. Coltella (2013) [7] | Italy | Rome | June 2010 to October 2011 |
Bryan H. Schmitt (2012) [36] | USA | Minnesota | 2012 |
N. Wüppenhorst (2012) [37] | Germany | Freiburg | NM |
Silvia Vega-Casta˜no (2012) [38] | Spain | Salamanca | NM |
Rémi Fournier (2012) [39] | France | Lille | NM |
M. Knoester (2012) [40] | The Netherlands | Leiden | January 2010 to February 2011 |
D. P. Fedorko (2012) [41] | USA | Bethesda | NM |
Ulrik Stenz Justesen (2011) [14] | Denmark | Vejle | November 2007 to October 2010 |
Esther Culebras (2011) [42] | Spain | Madrid | 2004–2006 |
Bernard La Scola (2011) [13] | France | Marseille | 2009–2010 |
A. C. M. Veloo (2011) [43] | The Netherlands | Leiden | NM |
A.C.M. Velooa (2011) [44] | The Netherlands | Groningen | NM |
Bacterial isolates
Performance of the MS system
Genus | Proportion | 95%CI | Weight% |
---|---|---|---|
Bacteroides | 96% | 95–97% | 6.79 |
Lactobacillus | 95% | 89–102% | 5.16 |
Parabacteroides | 94% | 87–101% | 4.88 |
Clostridium | 92% | 90–93% | 6.73 |
Propionibacterium | 91% | 89–93% | 6.55 |
Prevotella | 91% | 88–93% | 6.48 |
Veillonella | 91% | 85–197% | 5.25 |
Peptostreptococcus | 90% | 85–95% | 5.60 |
Bifidobacterium | 89% | 76–103% | 2.60 |
Solobacterium | 88% | 73–104% | 2.27 |
Finegoldia | 87% | 83–91% | 5.96 |
Capnocytophaga | 86% | 60–112% | 1.01 |
Parvimonas | 86% | 82–91% | 5.78 |
Peptoniphilus | 86% | 81–91% | 5.59 |
Slackia | 83% | 67–98% | 2.24 |
Actinomyces | 81% | 74–89% | 4.66 |
Ruminococcus | 80% | 45–115% | 0.59 |
Tissierella | 80% | 45–115% | 0.59 |
Fusobacterium | 79% | 74–84% | 5.61 |
Eggerthella | 74% | 63–85% | 3.39 |
Actinobaculum | 68% | 46–91% | 1.26 |
Atopobium | 68% | 51–85% | 1.92 |
Anaerococcus | 64% | 54–73% | 3.92 |
Flavonifracter | 63% | 29–96% | 0.64 |
Eubacterium | 57% | 20–94% | 0.55 |
Bilophila | 56% | 23–88% | 0.68 |
Butyricimonas | 56% | 23–88% | 0.68 |
Porphyromonas | 50% | 36–64% | 2.59 |
Subgroup meta-analyses
Genus | Numbera | MALDI biotyperb | Vitekb |
---|---|---|---|
Parabacteroides | 42/6 | 100% (I2 = 0.0%, P > 0.01) | 72% (I2 = 83.3%, P > 0.01) |
Peptostreptococcus | 41/91 | 100% (I2 = 0.0%, P > 0.01) | 97% (I2 = 76.6%, P > 0.01) |
Eggerthella | 36/26 | 100% (I2 = 21.8%, P > 0.01) | 77% (I2 = 0.0%, P > 0.01) |
Parvimonas | 205/7 | 100% (I2 = 35.5%, P > 0.01) | 98% (I2 = 19.0%, P > 0.01) |
Clostridium | 779/820 | 98% (I2 = 63.5%, P < 0.01) | 94% (I2 = 96.7%, P < 0.01) |
Finegoldia | 233/17 | 98% (I2 = 77.8%, P < 0.01) | 99% (I2 = 2.0%, P > 0.01) |
Prevotella | 404/105 | 92% (I2 = 84.1%, P < 0.01) | 92% (I2 = 0.0%, P > 0.01) |
Bacteroides | 1517/435 | 97% (I2 = 89.4%, P < 0.01) | 96% (I2 = 74.8%, P < 0.01) |
Fusobacterium | 214/34 | 91% (I2 = 89.7%, P < 0.01) | 92% (I2 = 84.8%, P = 0.01) |
Propionibacterium | 605/6 | 90% (I2 = 91.6%, P < 0.01) | 100% (I2 = 0.0%, P > 0.01) |
Peptoniphilus | 41/91 | 85% (I2 = 92.4%, P < 0.01) | 62% (I2 = 96.8%, P < 0.01) |
Actinomyces | 79/28 | 74% (I2 = 94.5%, P < 0.01) | 74% (I2 = 0.0%, P > 0.01) |
Sequence identifcation | MALDI-TOF MS identifcation | System | Reference |
---|---|---|---|
Actinomyces georgiae | Capnocytophaga gingivalis | bioMérieux Vitek MS | [27] |
Actinomyces graevenitzii | Actinomyces turicensis | Bruker MALDI Biotyper | [7] |
Actinomyces meyeri | Actinomyces odontolyticus | Bruker MALDI Biotyper | [58] |
Actinomyces viscosus | Actinomyces oris | Bruker MALDI Biotyper | [58] |
Anaerococcus hydrogenalis | Bacteroides fragilis | Bruker MALDI Biotyper | [24] |
Anaerococcus tetradius | Brevibacillus spp. | bioMérieux Vitek MS | [31] |
Bacteroides cellulosilyticus | Bacteroides intestinalis | Bruker MALDI Biotyper | [3] |
Bacteroides dorei | Bacteroides vulgatus | Bruker MALDI Biotyper | |
Bacteroides faecis | Bacteroides thetaiotaomicron | Bruker MALDI Biotyper | [58] |
Bacteroides faecis | Bacteroides thetaiotaomicron | bioMérieux Vitek MS | [27] |
Bacteroides nordii | Bacteroides thetaiotaomicron | bioMérieux Vitek MS | [27] |
Bacteroides vulgatus | Bacteroides eggerthii | bioMérieux Vitek MS | [31] |
Clostridium baratii | Clostridium paraputrificum | bioMérieux Vitek MS | [20] |
Clostridium beijerinckii | Clostridium butyricum | bioMérieux Vitek MS | [20] |
Clostridium bifermentans | Clostridium sordellii | bioMérieux Vitek MS | [20] |
Clostridium bolteae | Clostridium clostridioforme | bioMérieux Vitek MS | [27] |
Clostridium butyricum | Clostridium beijerinckii | bioMérieux Vitek MS | [20] |
Clostridium cadaveris | Clostridium sordellii | bioMérieux Vitek MS | [20] |
Clostridium clostridioforme | Bacillus ssp. | bioMérieux Vitek MS | [20] |
Clostridium difficile | Clostridium septicum | bioMérieux Vitek MS | [20] |
Clostridium difficile | Enterococcus faecium | Bruker MALDI Biotyper | [24] |
Clostridium histolyticum | C. sordellii/C. septicum | bioMérieux Vitek MS | [20] |
Clostridium limosum | Clostridium tyrobutyricum | bioMérieux Vitek MS | [20] |
Clostridium perfringens | Enterococcus faecalis | Bruker MALDI Biotyper | [24] |
Clostridium sordellii | Clostridium bifermentans | bioMérieux Vitek MS | [20] |
Clostridium sporogenes | C.difficile/ C.glycolicum | bioMérieux Vitek MS | [20] |
Clostridium tetani | Clostridium septicum | bioMérieux Vitek MS | [20] |
Fusobacterium nucleatum | Enterococcus faecalis | Bruker MALDI Biotyper | [24] |
Fusobacterium nucleatum | Fusobacterium naviforme | Bruker MALDI Biotyper | [26] |
Mogibacterium timidum | Clostridium halophilum | Bruker MALDI Biotyper | [58] |
Parvimonas micra | Slackia exigua | Bruker MALDI Biotyper | [24] |
Peptoniphilus Indolicus | Peptoniphilus harei | Bruker MALDI Biotyper | |
Porphyromonas gulae | Porphyromonas gingivalis | Bruker MALDI Biotyper | [58] |
Prevotella bivia | Streptococcus anginosus | Bruker MALDI Biotyper | [24] |
Prevotella denticola | Bacteroides fragilis | Bruker MALDI Biotyper | [24] |
Prevotella oralis | Prevotella nanciencis | Bruker MALDI Biotyper | [58] |
Prevotella oris | Prevotella buccae | Bruker MALDI Biotyper | [24] |
Veillonella dispar | Veillonella parvula | Bruker MALDI Biotyper | [7] |
Veillonella dispar | Veillonella parvula | bioMérieux Vitek MS | [27] |